The novel anthracenedione, pixantrone, lacks redox activity and inhibits doxorubicinol formation in human myocardium: insight to explain the cardiac safety of pixantrone in doxorubicin-treated patients. (Q43906042)
Jump to navigation
Jump to search
scientific article published on 28 November 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The novel anthracenedione, pixantrone, lacks redox activity and inhibits doxorubicinol formation in human myocardium: insight to explain the cardiac safety of pixantrone in doxorubicin-treated patients. |
scientific article published on 28 November 2012 |
Statements
The novel anthracenedione, pixantrone, lacks redox activity and inhibits doxorubicinol formation in human myocardium: insight to explain the cardiac safety of pixantrone in doxorubicin-treated patients (English)
Odalys Gonzalez Paz
28 November 2012